-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on IDEAYA Biosciences, Lowers Price Target to $63

Benzinga·07/07/2026 12:23:54
Listen to the news
Truist Securities analyst Gregory Renza maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and lowers the price target from $65 to $63.